Blog
RSS FeedPosted by Michael Wonder on 05 Feb 2024
Call for time limits on PHARMAC's drug assessment process
4 February 2024 - The Cancer Society says it is great to see the new government invest in cancer drugs, ...
Posted by Michael Wonder on 02 Feb 2024
Prioritising pills for the people: getting new medicines on schedule a complex process, by New Zealand Doctor
2 February 2024 - The funding of pharmaceuticals is an issue that often makes its way into news headlines. PHARMAC Director, ...
Posted by Michael Wonder on 31 Jan 2024
New Zealand Pharmaceutical Schedule - 1 February 2024
1 February 2024 - The February 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 25 Jan 2024
PHARMAC joins global health technology assessment network
25 January 2024 - PHARMAC has joined the International Network of Agencies for Health Technology Assessment (INAHTA) - a network ...
Posted by Michael Wonder on 23 Jan 2024
PHARMAC - 2023 in review (Part 2)
23 January 2024 - This week, we have reviewed the listing of innovative (patent protected) health care technologies in the ...
Posted by Michael Wonder on 22 Jan 2024
PHARMAC publishes agenda for next month's PTAC meeting
18 January 2024 - Surprise, surprise yet another underwhelming agenda. ...
Posted by Michael Wonder on 16 Jan 2024
PHARMAC - 2023 in review
17 January 2024 - 2023 was yet another dismal year for New Zealanders in terms of them being able to ...
Posted by Michael Wonder on 01 Jan 2024
New Zealand Pharmaceutical Schedule - 1 January 2024
1 January 2024 - The January 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Dec 2023
Father of two has to get cancer treatment in Germany after PHARMAC complications
21 December 2023 - An Auckland man has resorted to treatment for an aggressive bone marrow cancer in Germany after ...
Posted by Michael Wonder on 21 Dec 2023
Future supply of new COVID-19 vaccines confirmed
20 December 2023 - A vaccine to combat the newer strains of COVID-19 has been approved and will be available ...
Posted by Michael Wonder on 12 Dec 2023
PHARMAC proposes to fund treatments for breast and blood cancer
12 December 2023 - PHARMAC is seeking feedback on a proposal to fund two new treatments for advanced breast cancer and ...
Posted by Michael Wonder on 07 Dec 2023
Evolving our approach to COVID-19 vaccines and treatments
6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...
Posted by Michael Wonder on 06 Dec 2023
PHARMAC’s new equity policy
6 December 2023 - PHARMAC is drafting its first Equity Policy which outlines the mahi PHARMAC does, can do, or needs ...
Posted by Michael Wonder on 06 Dec 2023
Being more strategic and coordinated when we collaborate
6 December 2023 - Like other health entities, PHARMAC is busy working on strategies to meet the requirements of the ...
Posted by Michael Wonder on 04 Dec 2023
PHARMAC publishes minutes from August 2023 PTAC meeting
3 December 2023 - The meeting was held on 17-18 August 2023. After looking at the agenda, one asks why did ...